These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 30179104)
1. Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver. Choi KJ; Jang JK; Lee SS; Sung YS; Shim WH; Kim HS; Yun J; Choi JY; Lee Y; Kang BK; Kim JH; Kim SY; Yu ES Radiology; 2018 Dec; 289(3):688-697. PubMed ID: 30179104 [TBL] [Abstract][Full Text] [Related]
2. Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis. Park HJ; Lee SS; Park B; Yun J; Sung YS; Shim WH; Shin YM; Kim SY; Lee SJ; Lee MG Radiology; 2019 Feb; 290(2):380-387. PubMed ID: 30615554 [TBL] [Abstract][Full Text] [Related]
3. Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker. Wang J; Tang S; Mao Y; Wu J; Xu S; Yue Q; Chen J; He J; Yin Y Hepatol Int; 2022 Jun; 16(3):627-639. PubMed ID: 35347597 [TBL] [Abstract][Full Text] [Related]
4. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images. Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S Radiology; 2018 Apr; 287(1):146-155. PubMed ID: 29239710 [TBL] [Abstract][Full Text] [Related]
5. Deep learning for staging liver fibrosis on CT: a pilot study. Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S Eur Radiol; 2018 Nov; 28(11):4578-4585. PubMed ID: 29761358 [TBL] [Abstract][Full Text] [Related]
6. The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis. Guo SL; Su LN; Zhai YN; Chirume WM; Lei JQ; Zhang H; Yang L; Shen XP; Wen XX; Guo YM Clin Radiol; 2017 Mar; 72(3):242-246. PubMed ID: 28341030 [TBL] [Abstract][Full Text] [Related]
7. Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes. Chang W; Lee JM; Yoon JH; Han JK; Choi BI; Yoon JH; Lee KB; Lee KW; Yi NJ; Suh KS Radiology; 2016 Jul; 280(1):88-97. PubMed ID: 26844364 [TBL] [Abstract][Full Text] [Related]
8. Deep residual nets model for staging liver fibrosis on plain CT images. Li Q; Yu B; Tian X; Cui X; Zhang R; Guo Q Int J Comput Assist Radiol Surg; 2020 Aug; 15(8):1399-1406. PubMed ID: 32556922 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. Pickhardt PJ; Malecki K; Kloke J; Lubner MG AJR Am J Roentgenol; 2016 Dec; 207(6):1194-1199. PubMed ID: 27575867 [TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model. Yin Y; Yakar D; Dierckx RAJO; Mouridsen KB; Kwee TC; de Haas RJ Eur Radiol; 2021 Dec; 31(12):9620-9627. PubMed ID: 34014382 [TBL] [Abstract][Full Text] [Related]
11. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085 [TBL] [Abstract][Full Text] [Related]
12. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus. Lubner MG; Jones D; Kloke J; Said A; Pickhardt PJ Br J Radiol; 2019 Jan; 92(1093):20180153. PubMed ID: 30182750 [TBL] [Abstract][Full Text] [Related]
13. Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI. Hectors SJ; Kennedy P; Huang KH; Stocker D; Carbonell G; Greenspan H; Friedman S; Taouli B Eur Radiol; 2021 Jun; 31(6):3805-3814. PubMed ID: 33201285 [TBL] [Abstract][Full Text] [Related]
14. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Smith AD; Branch CR; Zand K; Subramony C; Zhang H; Thaggard K; Hosch R; Bryan J; Vasanji A; Griswold M; Zhang X Radiology; 2016 Sep; 280(3):771-81. PubMed ID: 27089026 [TBL] [Abstract][Full Text] [Related]
15. Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease. Son JH; Lee SS; Lee Y; Kang BK; Sung YS; Jo S; Yu E Eur Radiol; 2020 Jun; 30(6):3486-3496. PubMed ID: 32055946 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive precise staging of liver fibrosis using deep residual network model based on plain CT images. Li Q; Kang H; Zhang R; Guo Q Int J Comput Assist Radiol Surg; 2022 Apr; 17(4):627-637. PubMed ID: 35194737 [TBL] [Abstract][Full Text] [Related]
17. A novel fast kilovoltage switching dual-energy computed tomography technique with deep learning: Utility for non-invasive assessments of liver fibrosis. Wada N; Fujita N; Ishimatsu K; Takao S; Yoshizumi T; Miyazaki Y; Oda Y; Nishie A; Ishigami K; Ushijima Y Eur J Radiol; 2022 Oct; 155():110461. PubMed ID: 35970119 [TBL] [Abstract][Full Text] [Related]
18. Non-invasive Assessment of Liver Fibrosis with ElastPQ: Comparison with Transient Elastography and Serologic Fibrosis Marker Tests, and Correlation with Liver Pathology Results. Lee JE; Shin KS; Cho JS; You SK; Min JH; Kim KH; Song IS; Cheon KS Ultrasound Med Biol; 2017 Nov; 43(11):2515-2521. PubMed ID: 28844464 [TBL] [Abstract][Full Text] [Related]